Research and experimental development on natural sciences and engineering
BIONOR IMMUNO AS
Operating profit
NOK −93,000
Equity
NOK −17.1m
Incorporated
2000
Share capital
NOK 984,000
Key figures · 2024
Current ratio
0.01
Equity ratio
-12415.0%
Key figures over time · 2024
| Key figures | 2024 | Trend |
|---|---|---|
| Lønnsomhet | ||
| Return on assets (%%) | -67.2% | |
| Likviditet | ||
| Current ratio | 0.01 | |
| Working capital | −17.1m | |
| Soliditet | ||
| Equity ratio (%%) | -12415.0% | |
| Debt-to-equity ratio | -1.01 | |
Source: Biztrac.no · Data from the Brønnøysund Register Centre and the Norwegian Tax Administration · Last updated 15.06.2026.